Nascent-stage drug-discovery organization creator that originates businesses in-house, incubates single ultra-orphan and rare-disease bets for years of operation and millions, and commits to very long advancement timelines.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Backs edge-technology founders, fund managers and ecosystem builders, delivering Opportunity Hub–integrated training (BTEI), capital pathways, and co-creation of place-based equity districts and wealth initiatives. The firm continues to build its presence across the venture capital landscape.
Crypto-native operators who architect token-first ecosystems via token design, governance, and collective bootstrapping, empowering founders construct enduring token economies from day one and backing 100+ on-chain projects.
Operates as a follow-on, game-developer–only investor building a curated global peer community that funds shared industry data, expert sessions and retreats; roughly one-third of invested companies are female-founded. With a disciplined investment approach, the team drives value for both founders and investors.
Invests at or before seed in nascent-stage life sciences, building companies via 4:59 Initiative, with partners taking short-term operating roles and focusing on capital efficiency and faster timelines. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Early-phase partner for founders building iconic, industry-transforming companies, demonstrated by two new funds totaling $347M. With a disciplined investment approach, the team drives value for both founders and investors.
Cannabis-technology specialist investing in med‑tech, ag‑tech, SaaS, marketplaces and deep‑tech (not plant‑touching), active in US, Canada, Israel, led by Micah Tapman with 90+ cannabis deals. With a disciplined investment approach, the team drives value for both founders and investors.
